Li Feng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Li Feng has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
Jie Sun
Department of Cardiology, Zhongshan City People's Hospital, Zhongshan, Guangdong, China
4 shared publications- Bing Hu
Department of Cardiology, Zhongshan City People's Hospital, Zhongshan, Guangdong, China
3 shared publications Yanxiang Sun
Department of Cardiology, Zhongshan City People's Hospital, Zhongshan, Guangdong, China
3 shared publications- Yanxiang Sun
Department of Cardiology, Zhongshan City People’ s Hospital, Zhongshan, China
3 shared publications - Bing Hu
Department of Cardiology
2 shared publications Fei Li
Department of Cardiology, Zhongshan City People's Hospital, Zhongshan, Guangdong, China
2 shared publications
Latest Publications
- 15 October 2025
- Published by Elsevier in Atherosclerosis
- Vol. 411, 120548
Alamandine suppresses vascular calcification through inhibition of ferroptosis
- 15 October 2025
- Published by Elsevier in Atherosclerosis
- Vol. 411, 120548
Alamandine suppresses vascular calcification through inhibition of ferroptosis
- Open Access
- 15 August 2025
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 26 (8) , 37415
Association of Oxidative Balance Score With All-Cause and Cardiovascular Mortality Among Hypertensive Adults
Background: The Oxidative Balance Score (OBS) is a new measure for assessing systemic oxidative stress, where higher scores indicate increased exposure to antioxidants. However, the relationship between the OBS and mortality in individuals with hypertension remains unclear. Methods: This study evaluated 8151 hypertensive individuals from the National Health and Nutrition Examination Survey (NHANES) (2001–2018), utilizing data from the National Death Index, tracked through December 31, 2019. The association between OBS and mortality (cardiovascular and all-cause) was examined using multivariable Cox regression models. Results: During a median follow-up of 9.7 years, which included 1692 deaths (461 of which were cardiovascular), multivariable Cox regression showed the highest quartile of OBS had significantly lower rates of all-cause mortality (hazard ratio (HR) 0.761, 95% CI: 0.635–0.912) and cardiovascular mortality (HR 0.553, 95% CI: 0.388–0.788) compared to those in the lowest quartile. An increase of one unit in the OBS was associated with a 1.9% reduction in all-cause mortality risk and a 3.7% reduction in cardiovascular mortality risk. This relationship remained consistent across various subgroup analyses, and spline regression supported a linear inverse trend. Conclusions: For adults with hypertension, an elevated OBS is independently associated with a lower risk of mortality both from all-cause and cardiovascular diseases, suggesting that higher antioxidant levels may be protective.
- 15 August 2025
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 26 (8) , 37415
Open AccessAssociation of Oxidative Balance Score With All-Cause and Cardiovascular Mortality Among Hypertensive Adults
Background: The Oxidative Balance Score (OBS) is a new measure for assessing systemic oxidative stress, where higher scores indicate increased exposure to antioxidants. However, the relationship between the OBS and mortality in individuals with hypertension remains unclear. Methods: This study evaluated 8151 hypertensive individuals from the National Health and Nutrition Examination Survey (NHANES) (2001–2018), utilizing data from the National Death Index, tracked through December 31, 2019. The association between OBS and mortality (cardiovascular and all-cause) was examined using multivariable Cox regression models. Results: During a median follow-up of 9.7 years, which included 1692 deaths (461 of which were cardiovascular), multivariable Cox regression showed the highest quartile of OBS had significantly lower rates of all-cause mortality (hazard ratio (HR) 0.761, 95% CI: 0.635–0.912) and cardiovascular mortality (HR 0.553, 95% CI: 0.388–0.788) compared to those in the lowest quartile. An increase of one unit in the OBS was associated with a 1.9% reduction in all-cause mortality risk and a 3.7% reduction in cardiovascular mortality risk. This relationship remained consistent across various subgroup analyses, and spline regression supported a linear inverse trend. Conclusions: For adults with hypertension, an elevated OBS is independently associated with a lower risk of mortality both from all-cause and cardiovascular diseases, suggesting that higher antioxidant levels may be protective.
- Open Access
- 19 May 2025
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 12 (4) , 2985-2992
The Effects of Early Exercise on Cardiovascular Biomarkers in Patients witH Congestive Heart Failure
Background: Exercise training improves functional outcomes in chronic heart failure (HF), but the effects of early in-hospital physical activity on cardiovascular biomarkers and prognosis in acute congestive heart failure (AHF) patients remain unclear. This study investigated the short-term impact of early rehabilitation on prognostic biomarkers—high-sensitivity troponin T (hs-TnT), N-terminal pro-B-type natriuretic peptide (NT-proBNP), soluble suppression of tumourigenesis-2 (sST2), galectin-3 (Gal-3) and endothelin-1 (ET-1)—and evaluated associations with clinical outcomes. Methods and results: A total of 118 hospitalized AHF patients (35 controls and 83 exercise group) underwent biomarker measurement before and after supervised rehabilitation using non-invasive cardiac output monitoring. Serum levels of NT-proBNP, hs-TnT, sST2, Gal-3, and ET-1 were analysed. Prognosis was assessed via 12-month follow-up for all-cause mortality. Statistical analysis included ANOVA for biomarker changes and Kaplan–Meier survival analysis. Post-intervention, NT-proBNP levels increased significantly in the exercise group (2900 ± 700 pg/mL to 3500 ± 760 pg/mL, P = 0.012), as did ET-1 (1.9 ± 0.4 pg/mL to 2.4 ± 0.5 pg/mL, P = 0.018). Hs-TnT, sST2 and Gal-3 showed no significant changes (all P > 0.05). Survival analysis demonstrated higher baseline hs-TnT [hazard ratio (HR) 2.1, 95% confidence interval (CI) 1.3–3.4] and greater NT-proBNP elevation post-exercise (ΔNT-proBNP HR 1.8, 95% CI 1.1–2.9) were independent predictors of mortality. Conclusions: Early in-hospital exercise in AHF patients transiently elevates NT-proBNP and ET-1, indicative of acute haemodynamic stress, without altering myocardial injury or fibrosis markers (hs-TnT, sST2 and Gal-3). Elevated baseline hs-TnT and post-exercise NT-proBNP increases correlate with poorer survival, highlighting their prognostic value in risk assessment.
- 19 May 2025
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 12 (4) , 2985-2992
Open AccessThe Effects of Early Exercise on Cardiovascular Biomarkers in Patients witH Congestive Heart Failure
Background: Exercise training improves functional outcomes in chronic heart failure (HF), but the effects of early in-hospital physical activity on cardiovascular biomarkers and prognosis in acute congestive heart failure (AHF) patients remain unclear. This study investigated the short-term impact of early rehabilitation on prognostic biomarkers—high-sensitivity troponin T (hs-TnT), N-terminal pro-B-type natriuretic peptide (NT-proBNP), soluble suppression of tumourigenesis-2 (sST2), galectin-3 (Gal-3) and endothelin-1 (ET-1)—and evaluated associations with clinical outcomes. Methods and results: A total of 118 hospitalized AHF patients (35 controls and 83 exercise group) underwent biomarker measurement before and after supervised rehabilitation using non-invasive cardiac output monitoring. Serum levels of NT-proBNP, hs-TnT, sST2, Gal-3, and ET-1 were analysed. Prognosis was assessed via 12-month follow-up for all-cause mortality. Statistical analysis included ANOVA for biomarker changes and Kaplan–Meier survival analysis. Post-intervention, NT-proBNP levels increased significantly in the exercise group (2900 ± 700 pg/mL to 3500 ± 760 pg/mL, P = 0.012), as did ET-1 (1.9 ± 0.4 pg/mL to 2.4 ± 0.5 pg/mL, P = 0.018). Hs-TnT, sST2 and Gal-3 showed no significant changes (all P > 0.05). Survival analysis demonstrated higher baseline hs-TnT [hazard ratio (HR) 2.1, 95% confidence interval (CI) 1.3–3.4] and greater NT-proBNP elevation post-exercise (ΔNT-proBNP HR 1.8, 95% CI 1.1–2.9) were independent predictors of mortality. Conclusions: Early in-hospital exercise in AHF patients transiently elevates NT-proBNP and ET-1, indicative of acute haemodynamic stress, without altering myocardial injury or fibrosis markers (hs-TnT, sST2 and Gal-3). Elevated baseline hs-TnT and post-exercise NT-proBNP increases correlate with poorer survival, highlighting their prognostic value in risk assessment.
- Open Access
- 19 February 2024
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 60, 289-297
Red and processed meat intake and risk of cardiovascular disease: A two-sample Mendelian randomization study
- 19 February 2024
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 60, 289-297
Open AccessRed and processed meat intake and risk of cardiovascular disease: A two-sample Mendelian randomization study
- Open Access
- 20 October 2023
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 209, 301-319
A novel circular RNA, circSQSTM1, protects the endothelial function in atherosclerosis
- 20 October 2023
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 209, 301-319
Open AccessA novel circular RNA, circSQSTM1, protects the endothelial function in atherosclerosis
- Open Access
- 25 August 2023
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 87 (9) , 1212-1218
Targeting the Efficacy of Intensive Blood Pressure Treatment in Hypertensive Patients ― An Exploratory Analysis of SPRINT ―
Background: Hypertensive patients show highly heterogeneous treatment effects (HTEs) and cardiovascular prognosis, and not all benefit from intensive blood pressure treatment.Methods and Results: We used the causal forest model to identify potential HTEs of patients in the Systolic Blood Pressure Intervention Trial (SPRINT). Cox regression was performed to assess hazard ratios (HRs) for cardiovascular disease (CVD) outcomes and to compare the effects of intensive treatment among groups. The model revealed 3 representative covariates and patients were partitioned into 4 subgroups: Group 1 (baseline body mass index [BMI] ≤28.32 kg/m2and estimated glomerular filtration rate [eGFR] ≤69.53 mL/min/1.73 m2); Group 2 (baseline BMI ≤28.32 kg/m2and eGFR >69.53 mL/min/1.73 m2); Group 3 (baseline BMI >28.32 kg/m2and 10-year CVD risk ≤15.8%); Group 4 (baseline BMI >28.32 kg/m2and 10-year CVD risk >15.8%). Intensive treatment was shown to be beneficial only in Group 2 (HR 0.54, 95% confidence interval [CI] 0.35–0.82; P=0.004) and Group 4 (HR 0.69, 95% CI 0.52–0.91; P=0.009).Conclusions: Intensive treatment was effective for patients with high BMI and 10-year CVD risk, or low BMI and normal eGFR, but not for those with low BMI and eGFR, or high BMI and low 10-year CVD risk. Our study could facilitate the categorization of hypertensive patients, ensuring individualized therapy.
- 25 August 2023
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 87 (9) , 1212-1218
Open AccessTargeting the Efficacy of Intensive Blood Pressure Treatment in Hypertensive Patients ― An Exploratory Analysis of SPRINT ―
Background: Hypertensive patients show highly heterogeneous treatment effects (HTEs) and cardiovascular prognosis, and not all benefit from intensive blood pressure treatment.Methods and Results: We used the causal forest model to identify potential HTEs of patients in the Systolic Blood Pressure Intervention Trial (SPRINT). Cox regression was performed to assess hazard ratios (HRs) for cardiovascular disease (CVD) outcomes and to compare the effects of intensive treatment among groups. The model revealed 3 representative covariates and patients were partitioned into 4 subgroups: Group 1 (baseline body mass index [BMI] ≤28.32 kg/m2and estimated glomerular filtration rate [eGFR] ≤69.53 mL/min/1.73 m2); Group 2 (baseline BMI ≤28.32 kg/m2and eGFR >69.53 mL/min/1.73 m2); Group 3 (baseline BMI >28.32 kg/m2and 10-year CVD risk ≤15.8%); Group 4 (baseline BMI >28.32 kg/m2and 10-year CVD risk >15.8%). Intensive treatment was shown to be beneficial only in Group 2 (HR 0.54, 95% confidence interval [CI] 0.35–0.82; P=0.004) and Group 4 (HR 0.69, 95% CI 0.52–0.91; P=0.009).Conclusions: Intensive treatment was effective for patients with high BMI and 10-year CVD risk, or low BMI and normal eGFR, but not for those with low BMI and eGFR, or high BMI and low 10-year CVD risk. Our study could facilitate the categorization of hypertensive patients, ensuring individualized therapy.
- Open Access
- 19 April 2023
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 41 (7) , 1152-1158
Childhood obesity and hypertension in pregnancy: a two-sample Mendelian randomization analysis
Background: The causal relationship between childhood obesity and hypertension in pregnancy remains unclear. To examine the causal association between childhood obesity and hypertension in pregnancy, two-sample Mendelian randomization analysis was applied. Methods: Single-nucleotide polymorphisms (SNPs) associated with childhood obesity were obtained from a published genome-wide association study (GWAS) of 13 848 European individuals. Summary-level data for hypertension in pregnancy were obtained from the FinnGen consortium (11534 cases and 162212 controls). Inverse-variance weighted analysis, weighted-median analysis, and Mendelian randomization-Egger regression were conducted in this Mendelian randomization analysis. Sensitivity analyses were conducted to confirm the accuracy and robustness of our results. Results: Genetically determined childhood obesity significantly affects hypertension in pregnancy by IVW [odds ratio (OR) = 1.161, 95% confidence interval (CI) 1.086–1.039; P = 9.92 × 10−6] and weighted median (OR = 1.123, 95% CI 1.038–1.214; P = 0.004). These results were validated by multiple sensitivity analyses. Conclusion: A causal effect between genetically predicted childhood obesity and the risk of hypertension in pregnancy was identified. The prevention of hypertension in pregnancy should be promoted in populations with childhood obesity.
- 19 April 2023
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 41 (7) , 1152-1158
Open AccessChildhood obesity and hypertension in pregnancy: a two-sample Mendelian randomization analysis
Background: The causal relationship between childhood obesity and hypertension in pregnancy remains unclear. To examine the causal association between childhood obesity and hypertension in pregnancy, two-sample Mendelian randomization analysis was applied. Methods: Single-nucleotide polymorphisms (SNPs) associated with childhood obesity were obtained from a published genome-wide association study (GWAS) of 13 848 European individuals. Summary-level data for hypertension in pregnancy were obtained from the FinnGen consortium (11534 cases and 162212 controls). Inverse-variance weighted analysis, weighted-median analysis, and Mendelian randomization-Egger regression were conducted in this Mendelian randomization analysis. Sensitivity analyses were conducted to confirm the accuracy and robustness of our results. Results: Genetically determined childhood obesity significantly affects hypertension in pregnancy by IVW [odds ratio (OR) = 1.161, 95% confidence interval (CI) 1.086–1.039; P = 9.92 × 10−6] and weighted median (OR = 1.123, 95% CI 1.038–1.214; P = 0.004). These results were validated by multiple sensitivity analyses. Conclusion: A causal effect between genetically predicted childhood obesity and the risk of hypertension in pregnancy was identified. The prevention of hypertension in pregnancy should be promoted in populations with childhood obesity.
- 30 November 2019
- Published by Springer Nature in American Journal of Cardiovascular Drugs
- Vol. 20 (4) , 333-342
Value of Galectin-3 in Acute Myocardial Infarction
Galectins are an ancient family of lectins characterized by evolutionarily conserved amino acid sequences and β-galactoside recognition and binding sites. Galectin-3 (Gal-3) is one of 15 known galectins. This protein has important functions in numerous biological activities, including cardiac fibrosis and heart failure. In recent years, many studies have shown that Gal-3 is closely associated with acute myocardial infarction (AMI) and may be a promising biomarker for the assessment of severity as well as prognosis prediction in AMI patients, but controversy still exists. In this review, we summarize the latest literature on the relationship between Gal-3 and unstable plaques, the secretion kinetics of Gal-3 during the acute phase of AMI, and the value of Gal-3 in the prediction of post-AMI remodeling. Finally, the possible value of Gal-3 as a biological target for AMI therapy is examined.
- 30 November 2019
- Published by Springer Nature in American Journal of Cardiovascular Drugs
- Vol. 20 (4) , 333-342
Value of Galectin-3 in Acute Myocardial Infarction
Galectins are an ancient family of lectins characterized by evolutionarily conserved amino acid sequences and β-galactoside recognition and binding sites. Galectin-3 (Gal-3) is one of 15 known galectins. This protein has important functions in numerous biological activities, including cardiac fibrosis and heart failure. In recent years, many studies have shown that Gal-3 is closely associated with acute myocardial infarction (AMI) and may be a promising biomarker for the assessment of severity as well as prognosis prediction in AMI patients, but controversy still exists. In this review, we summarize the latest literature on the relationship between Gal-3 and unstable plaques, the secretion kinetics of Gal-3 during the acute phase of AMI, and the value of Gal-3 in the prediction of post-AMI remodeling. Finally, the possible value of Gal-3 as a biological target for AMI therapy is examined.